CTS Research Consortium was established to further CTS’s leadership in infectious disease research. This collaboration between Vitalant Research Institute, Carter BloodCare, OneBlood, ITxM, New York Blood Center and Bloodworks Northwest will provide a wealth of data for the development of future hypothesis-based research studies.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...